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Some nutrients, such as carbohydrate, fat and protein, are known to stimulate satiety. However, the effect
of sn-2-monoacylglycerol (2-MG), one of the digestive products of triglycerides, on food intake is still
unclear. In the present study, the effects of 2-MG on food intake and diarrhea were evaluated and
compared with long-chain fatty acid (LCFA) in rats by intrajejunal infusion.
Intrajejunal infusion of 2-MG reduced food intake. In addition, 2-MG did not induce diarrhea at the
condition that it comparably reduced food intake as compared with LCFA. These results suggest that 2-
MG stimulates satiety without inducing diarrhea, different from LCFA.
© 2016 Japanese Pharmacological Society. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).The physiological regulation of food intake involves signals from
the gastrointestinal tract as well as from the central nervous sys-
tem. Indeed, dietary fat, carbohydrate and protein stimulate satiety
signals (1e3). Understandably, since overconsumption of nutrients
consequently causes an over intake of calories and obesity, this
satiety signal may be against overeating. On the other hand, over-
consumption of nutrients also causes malabsorption, which leads
to gastrointestinal symptoms.
Long-chain fatty acid (LCFA) and sn-2-monoacylglycerol (2-
MG) are both digestive products of dietary triglyceride (TG) hy-
drolysis. Typically, these digestive products are absorbed in the
upper intestine, however, if these products reach to the distal
intestine, they may stimulate a feedback signal for satiety (4e6).
The function of LFCA, one of the digestive products of TG, in the
intestine has been well investigated. LCFA reportedly suppresses
appetite in humans (7) and rats (8,9). The mechanism of induction
of satiety by intestinal LCFA is mainly understood via gastroin-
testinal peptide secretion such as glucagon-like peptide-1 (GLP-
1), peptide YY (PYY) and cholecystokinin (CCK). On the other).
rmacological Society.
. Production and hosting by Elsehand, LCFA stimulates not only satiety, but gastrointestinal (GI)
symptoms. The malabsorption of LCFA is known to induce diar-
rhea (10). In contrast, the function of 2-MG in the intestine is still
unclear. In the present study, the effect of 2-MG on food intake
and diarrhea was evaluated and compared to the effect of LCFA in
rats. To correctly investigate the effect in the intestine, 2-MG and
LCFA were directly infused into the jejunum.
Male Sprague Dawley rats were purchased from Charles River
Laboratories (Yokohama, Japan). Rats were maintained with free
access to water and a normal chow diet (CRF-1, Charles River Japan)
and housed in a room controlled for temperature at 23 ± 3 C and
humidity of 55 ± 15% in 12-h light/dark cycles (lights on from 8:00
AM to 8:00 PM). All procedures were conducted according to
guidelines from Japan Tobacco's Animal Care Committee.
Prior to surgery, the rats were fasted overnight and then anes-
thetized with 50 mg/kg of intraperitoneal pentobarbital sodium
(Abbott Laboratories, Chicago, IL). After abdominal celiotomy, a
polyethylene tube (SP28; I.D. 0.4 mm, O.D. 0.8; mm, Natsume,
Tokyo, Japan) was inserted into the duodenum (5 cm from the
pylorus). The end of the tube reached the proximal jejunum (10 cm
from the pylorus). The tube was ﬁxed to the entrance of the in-
testine with silk sutures. The opposite end of the tubewas threaded
through the opening in the abdominal wall and tunneled subcu-
taneously to the dorsal surface of the neck, where a Dacron meshvier B.V. This is an open access article under the CC BY-NC-ND license (http://
C. Okuma et al. / Journal of Pharmacological Sciences 130 (2016) 136e138 137anchor button (DC95; Instech Solomon, PlymouthMeeting, PA) was
implanted. The tube was also ﬁxed to the ventral abdominal wall
and the anchor button mesh using silk sutures. The rats were
allowed to recover for 1 week and become sufﬁciently adapted to
the continuous infusion apparatus (Instech Solomon) before ex-
periments were performed.
In the feeding test, the chow was removed and immediately
after that, 2-MG (2-monolein, synthesized by Japan Tobacco Central
Pharmacological Research Institute), LCFA (linoleic acid, commer-
cial grade (~60% linoleic acid, ~30% oleic acid), Sigma, St. Louis, MO),
or salinewere infused intrajejunally for 4 h in rats. Since ratsmainly
feed during the dark period, the feeding was restarted at beginning
of dark period (1 h after starting the infusion). Cumulative food
intake was measured for 3 h, 6 h and 23 h.
In the experiment 1, we evaluated the effect of L2-MG and LCFA
on food intake in three separate crossover studies. 2-MG at a rate of
200 mL/h, 300 mL/h and LCFA at a rate of 200 mL/h were infused to
separate animals. The jejunal infusion of respective lipids or saline
was performed on separate days. Statistical analysis was performed
using paired t-tests. In experiment 2, stool characteristics were
observed after infusion of respective lipids to evaluate diarrhea
induction. Similar to experiment 1, jejunal infusions of 2-MG, LCFA
or saline were performed on separate days. Statistical analysis was
performed using Fisher's exact test. In experiment 3, to evaluate
water contents, whole cecal contents were collected from scariﬁed
rats at 4 h after infusion of respective lipids or saline. Total waterFig. 1. The effects of intrajejunal 2-MG and LCFA infusion on food intake in rats. (A) Cumulati
(n ¼ 8/group) (B) Cumulative food intake in rats after jejunal infusion of 2-MG or saline at
infusion of LCFA or saline at a rate of 200 mL/h for 4 h (n ¼ 6/group). **P < 0.01 vs. saline tcontents were calculated from the differences in cecal contents
weight before and after drying. Statistical analysis was performed
using Turkey's multiple comparison tests.
In experiment 1, the intrajejunal infusion of 2-MG resulted in
reduced food intake at both infusion rate of 200 mL/h and 300 mL/h
in rats (Fig. 1). This effect in the 300 mL/h 2-MG treated group
appeared to be clearer than in the 200 mL/h 2-MG treated group.
The effect in the 300 mL/h of 2-MG treated group was continuously
observed after the completion of infusion. Similar to another report
(8), the intrajejunal infusion of LCFA reduced food intake in our
experiment. The efﬁcacy in the 300 mL/h 2-MG and the 200 mL/h
LCFA treated groups seemed comparable.
As mentioned above, nutrients are known to stimulate satiety to
prevent overeating. Considering this, 2-MG, one of the digestive
products of triglycerides, may stimulate satiety signals as a feed-
back mechanism for overeating. In the preliminarily study, we
evaluated portal plasma GLP-1 levels in 2-MG (300 mL/h) and LCFA
(200 mL/h) treated animals. At 2 h after starting the infusion (1 h
after starting feeding), the rats were anesthetized with diethyl
ether and blood was collected from the portal vein into siliconized
tubes on ice containing approximately 5% of EDTA, aprotinin, and a
dipeptidyl peptidase IV (DPP-IV) inhibitor (ﬁnal concentrations of
EDTA, aprotinin and DPP-IV inhibitor (Millipore Corporation) were
6 mmol/l, 1  103 KIU/ml and 50 mmol/l, respectively). Plasma was
isolated by centrifugation at 10,000 g for 30 min at 4 C. Plasma
active GLP-1 levels were measured via a sandwich enzymeve food intake in rats after jejunal infusion of 2-MG or saline at a rate of 200 mL/h for 4 h
a rate of 300 mL/h for 4 h (n ¼ 6/group) (C) Cumulativefood intake in rats after jejunal
reatment (paired t-test).
Table 1
Incidence of diarrhea after intrajejunal infusion of 2-MG and LCFA in rats. 2-MG,
LCFA or saline was intrajejunally infused for 4 h in rats. The feeding was restarted 1 h
after starting the infusion. Stools were observed 23 h after starting the feeding.
*P < 0.05 vs. saline treatment (Fisher's exact test).
Treatment Saline 2-MG LCFA
Number of animals observed diarrhea 0 0 4
Total number of animals 6 6 6
Signiﬁcance e e *
Fig. 2. The effects of intrajejunal 2-MG, LCFA and saline infusion on cecal water con-
tents in rats (n ¼ 5e6/group). *P < 0.05 vs. saline treatment (Tukey multiple
comparisons).
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LCFA tended to increase portal plasma GLP-1 levels (26 and 29 pM
in the saline treated group (n ¼ 2), 107, 76 and 190 pM in the 2-MG
treated group (n ¼ 3) and 218, 134 and 115 pM in the LCFA treated
group (n ¼ 3)). Therefore, increases in GLP-1 levels may partly
contribute to the effect of 2-MG on food intake. However, the exact
mechanisms for the satiety effect of 2-MG and decreases in food
intake are still unclear. Further investigations are needed to clarify
the contribution of gastrointestinal peptide secretion (including
PYY and CCK) and/or the vagal afferent pathway for this effect of 2-
MG.
In experiment 1, when food weight was measured, we noticed
that some diarrheal stools were observed in LCFA treated rat but
not in 2-MG treated rats. We therefore postulated that the sensi-
tivity for gastrointestinal symptoms, such as diarrhea, is different
between LCFA and 2-MG. We then compared the effect of intra-
jejunal infusion of 2-MG and LCFA on diarrhea (experiment 2). As
shown in Table 1, in LCFA treated rats, diarrheal stools were
observed in 4 out of 6 rats 23 h after starting feeding and this
change was statistically signiﬁcant. In contrast, in 2-MG treated
rats, diarrheal stools were not observed in all rats. LCFA reportedly
inhibited water and electrolyte absorption in the ileum, which may
lead to steatorrhea and diarrhea in humans (11). Therefore, diar-
rhea induced by LCFA is interpreted that secretory diarrhea. Indeed,
intrajejunal infusion of LCFA induced watery diarrhea in experi-
ment 2. However, even though the efﬁcacy of 2-MG on food intake
reduction was almost the same as compared to LCFA, 2-MG did not
induce diarrhea. To investigate into the mechanism of secretory
diarrhea induction, we evaluated the water content in cecal con-
tents in 2-MG (300 mL/h) and LCFA (300 mL/h) treated rats at 3 h
after starting feeding (diarrhea was observed from 3 to 23 h after
starting feeding in LCFA treated group in experiment 2). As shown
in Fig. 2, the intrajejunal infusion of LCFA signiﬁcantly increased
cecal water contents. The values in LCFA treated groupwere 2 timeshigher as compared to that in saline treated group. In contrast, the
intrajejunal infusion of 2-MG did not change cecal water contents.
From these, there is a probability that the difference of reactivity on
ﬂuid secretion between 2-MG and LCFA contributes their diarrhea
inducibility. Although in-depth investigations are needed to
conﬁrm these mechanisms, the difference of diarrhea inducibility
by both triglyceride digestive products is quite an interesting
phenomenon.
The deletion of monoacylglycerol acyltransferase 2 (MGAT2),
which converts 2-MG to diacylglycerol, is known to reduce food
intake in high fat diet fed mice (12). In addition, a MGAT inhibitor
increased intestinal monoacylglycerol content after lipid loading
and decreased food intake only when fed a high fat diet (13).
Moreover, transgenic mice that overexpress monoacylglycerol
lipase (MGL), which converts monoacylglycerols to LCFA and
glycerol speciﬁcally in small intestine, were hyperphagic (14).
In conclusion, we demonstrated that jejunal infusion of 2-MG
reduced food intake in rats. These results may contribute to un-
derstanding the phenomenon in MGAT2 deﬁcient mice, MGL
transgenic mice and MGAT inhibitors. In addition, 2-MG did not
induce diarrhea at the condition that it comparably reduced food
intake as compared to LCFA, suggesting that 2-MG may become a
unique and useful fat substitute in clinical, which stimulate satiety
without inducing diarrhea.
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